MedicaidPrior AuthMedium impact
2023.02 Provider Bulletin - Policy Updates and Changes to Clinical Review Criteria 02.14.2023 pdf
Connecticut Medicaid (HUSKY Health)·CT · Endocrinology, Ophthalmology, Urology +2 more·Provider Bulletin
Effective date
Feb 1, 2023
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid has introduced new prior authorization requirements for Tepezza® (teprotumumab-trbw) effective February 1, 2023, and updated clinical review criteria for Continuous Glucose Monitors, Incontinence Supplies, and Gender Affirmation Surgery. Providers must obtain prior authorization through the new PA form before administering or prescribing these services.
Action Required
Immediately: Billing team must obtain prior authorization for all Tepezza® (teprotumumab-trbw) prescriptions using the new PA form available at https://portal.ct.gov/husky. Update billing workflows to require prior auth verification before submitting claims for Continuous Glucose Monitors, Incontinence Supplies, and Gender Affirmation Surgery. Contact CHNCT at 1-800-440-5071 for prior authorization questions. Claims submitted without proper authorization will be denied.